Numab Therapeutics AG has a total of 66 patent applications. It increased the IP activity by 1333.0%. Its first patent ever was published in 2014. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are LAZAR GREGORY ALAN, TENEOBIO INC and ULTRAHUMAN EIGHT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 13 | |
#2 | EPO (European Patent Office) | 13 | |
#3 | Canada | 8 | |
#4 | United States | 8 | |
#5 | Republic of Korea | 6 | |
#6 | Israel | 4 | |
#7 | Singapore | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Brazil | 1 | |
#10 | Chile | 1 | |
#11 | China | 1 | |
#12 | Colombia | 1 | |
#13 | Hong Kong | 1 | |
#14 | Japan | 1 | |
#15 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Gunde Tea | 49 |
#2 | Hess Christian | 48 |
#3 | Meyer Sebastian | 40 |
#4 | Simonin Alexandre | 38 |
#5 | Urech David | 34 |
#6 | Brock Matthias | 27 |
#7 | Warmuth Stefan | 15 |
#8 | Bieri Tessa | 5 |
#9 | Beltrametti Teddy | 5 |
#10 | Christian Hess | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020157305A1 | Multispecific antibodies having specificity for tnfa and il-17a, antibodies targeting il-17a, and methods of use thereof | |
EP3816185A1 | Multispecific antibody directed against pd-l1 and a tumor-associated antigen | |
TW202035457A | Antibodies targeting cd137 and methods of use thereof | |
EP3689907A1 | Antibodies targeting il-17a and methods of use thereof | |
SG11202003111SA | Antibodies targeting cd137 and methods of use thereof | |
AU2018348430A1 | Antibodies targeting PDL1 and methods of use thereof | |
EP3636320A1 | Antibodies targeting cd137 and methods of use thereof | |
EP3694873A1 | Multispecific antibody | |
CA3064163A1 | Novel anti-cd3 antibodies | |
AU2018280679A1 | Novel anti-HSA antibodies | |
CA3065868A1 | Hetero-dimeric multi-specific antibody format targeting at least cd3 and hsa | |
EP3470426A1 | Multispecific antibody |